13-50843338-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001306135.2(DLEU7):c.309C>A(p.Phe103Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000257 in 1,476,046 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001306135.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLEU7 | NM_001306135.2 | c.309C>A | p.Phe103Leu | missense_variant | 1/2 | ENST00000504404.2 | NP_001293064.1 | |
DLEU7 | NM_198989.3 | c.309C>A | p.Phe103Leu | missense_variant | 1/2 | NP_945340.2 | ||
DLEU7-AS1 | NR_046551.1 | n.438+3244G>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLEU7 | ENST00000504404.2 | c.309C>A | p.Phe103Leu | missense_variant | 1/2 | 1 | NM_001306135.2 | ENSP00000427177.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000893 AC: 9AN: 100832Hom.: 0 AF XY: 0.000106 AC XY: 6AN XY: 56576
GnomAD4 exome AF: 0.0000279 AC: 37AN: 1323806Hom.: 0 Cov.: 30 AF XY: 0.0000370 AC XY: 24AN XY: 648796
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | The c.309C>A (p.F103L) alteration is located in exon 1 (coding exon 1) of the DLEU7 gene. This alteration results from a C to A substitution at nucleotide position 309, causing the phenylalanine (F) at amino acid position 103 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at